Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0T9PL
|
|||
Former ID |
DIB011072
|
|||
Drug Name |
BLV-0703
|
|||
Synonyms |
BLV-200703; KTP-NH2; TAU-targeting compound (CNS disorders), Bioalvo
Click to Show/Hide
|
|||
Indication | Central nervous system disease [ICD-11: 8A04-8D87; ICD-10: G00-G99] | Investigative | [1] | |
Company |
Bioalvo SA
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Microtubule-associated protein tau (MAPT) | Target Info | Modulator | [1] |
KEGG Pathway | MAPK signaling pathway | |||
Alzheimer's disease | ||||
NetPath Pathway | IL2 Signaling Pathway | |||
EGFR1 Signaling Pathway | ||||
Pathway Interaction Database | LPA receptor mediated events | |||
Reelin signaling pathway | ||||
Reactome | Caspase-mediated cleavage of cytoskeletal proteins | |||
WikiPathways | Notch Signaling Pathway | |||
IL-2 Signaling Pathway | ||||
MAPK Signaling Pathway | ||||
Copper homeostasis | ||||
Kit receptor signaling pathway | ||||
BDNF signaling pathway | ||||
Integrated Pancreatic Cancer Pathway | ||||
Alzheimers Disease | ||||
Regulation of Microtubule Cytoskeleton | ||||
Apoptotic execution phase | ||||
IL-5 Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Microtubules (tau) as an emerging therapeutic target: NAP (davunetide). Curr Pharm Des. 2011;17(31):3413-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.